Group 1 - Treasury yields are increasing as investors adjust their growth and inflation expectations following a quarter-point interest-rate cut by the Federal Reserve [1][2] - The Federal Reserve has raised its GDP growth estimates for this year and next, with stronger growth anticipated in 2027, while also slightly lowering its unemployment forecast [2] - Fed officials indicated the possibility of two additional quarter-point rate cuts by the end of the year and another reduction in 2026, highlighting concerns over softer job growth despite inflation risks [2]

Loulo-Gounkoto complex. (Image by Barrick Gold). Malian prosecutors have appealed a judge’s order to release four employees of Barrick Mining (NYSE: B) on bail, extending the legal uncertainty around the Canadian miner’s operations in the country, Bloomberg reported on Thursday.The employees — including a regional manager detained late last year — will remain in jail until the Court of Appeal reviews the prosecution’s case, according to people familiar with the matter. The judge had set bail at 50 billion C ...

Core Insights - Biogen's Zurzuvae (zuranolone) has received approval from the European Commission for the treatment of postpartum depression (PPD) in adults, making it the first and only approved treatment for this indication in the European Union [1][7] - The approval is based on the successful phase III SKYLARK study, which demonstrated rapid and sustained relief from depressive symptoms [2][7] - Biogen's stock has underperformed this year, with a 5% decline compared to a 3% growth in the industry [3] Product Performance - Zurzuvae was launched in the United States in December 2023, and sales reached $46.4 million in Q2 2025, reflecting a 68% increase sequentially due to rising demand [6][7] - The drug's launch exceeded Biogen's internal expectations, indicating strong market acceptance [6][7] Strategic Partnerships - Zurzuvae was developed in collaboration with Sage Therapeutics, which has been acquired by Supernus Pharmaceuticals. Biogen and Supernus share profits and losses from the commercialization of Zurzuvae in the U.S. [5] Future Growth Potential - Zurzuvae is one of four new product launches by Biogen, alongside Leqembi for Alzheimer's disease, Skyclarys for Friedreich's Ataxia, and Qalsody for ALS, which are expected to drive long-term growth [8]

Interested in more income ideas? Check out Cash Builder Opportunities, where we provide ideas about high-quality and reliable dividend growth ideas. These investments are designed to build growing income for investors. A special focus on investments that are leaders within their industry to provide stability and long-term wealth creation. Along with this, the service provides ideas for writing options to build investors' income even further.Join us today to have access to our portfolio, watchlist and live c ...

U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Thursday.Shares of Radian Group Inc. RDN rose sharply during Thursday's session after the company announced it entered into a definitive agreement to acquire Inigo for $1.7 billion.The deal, funded primarily with cash on hand and excess subsidiary capital, values Inigo at 1.5 times its expected 2025 tangible equity. It is projected to close in the first quarter of 2026 and nearly double Radian's revenue while boosting earning ...

ATLANTA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK). The lawsuit alleges Defendants represented that Cytokinetics expected approval from the U.S. Food and Drug Administration ("FDA") for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 PDUFA date, and failed to disclose material risks related to the Company's failure to submit a Risk Evaluation and Miti ...

ServiceNow Inc. is expanding to West Palm Beach, Florida, opening a location for several hundred employees in a planned office tower being developed by billionaire Stephen Ross, the famed New York real estate magnate who broke from Related Cos. last year to focus on his Florida projects under the name Related Ross.The Santa Clara, California-based software company said Tuesday it’s leasing 200,000 square feet (18,600 square meters) in Ross’ development, which will include a new artificial intelligence “inst ...

Wall Street bank Citi (C) has raised its price target on Bullish (BLSH), the owner of CoinDesk, to $70 from $66 after the crypto exchange’s second quarter results came in slightly ahead of expectations. The long-anticipated NYDFS BitLicense approval removes a key regulatory overhang, strengthening investor confidence heading into FY 2026, Citi said. But the biggest surprise, according to the bank, was Bullish’s accelerating Subscription, Services and Other (SS&O) growth pipeline, an inflection it attribu ...

Analysts at TD Cowen surveyed 215 companies on their cloud spending plans — an annual process they say "has been predictive of critical industry trends†since 2012. ...

The Platinum Card® from American Express is getting a major update — along with a new price tag. After teasing new updates earlier this year, Amex is overhauling both of its most premium cards, the Platinum Card and The Business Platinum Card® from American Express. In addition to a new, limited-edition mirror design, the revamped cards will offer brand-new annual credits, enhanced benefits, and more. Here’s everything to know, whether you’re an existing Platinum cardholder or considering whether a premiu ...